AVADEL PHARMACEUTICALS PLC financial data

Symbol
AVDL on Nasdaq
Location
Dublin 2
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 276 % -9.33%
Quick Ratio 40.2 % +33.6%
Debt-to-equity 113 % +4.57%
Return On Equity 23.4 %
Return On Assets 11 %
Operating Margin 1.82 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97.7M shares +1.34%
Common Stock, Shares, Outstanding 97.2M shares +0.93%
Entity Public Float 1.34B USD -8.02%
Common Stock, Value, Issued 972K USD +0.94%
Weighted Average Number of Shares Outstanding, Basic 97.1M shares +0.84%
Weighted Average Number of Shares Outstanding, Diluted 101M shares +5.17%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 249M USD +79.9%
Research and Development Expense 39.9M USD +200%
Costs and Expenses 144M USD +46.3%
Operating Income (Loss) 4.52M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.85M USD +94.5%
Income Tax Expense (Benefit) -2.98M USD -596%
Net Income (Loss) Attributable to Parent 19.7M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79.8M USD +179%
Marketable Securities, Current 11.8M USD -68.4%
Accounts Receivable, after Allowance for Credit Loss, Current 42.4M USD +14.4%
Inventory, Net 23.9M USD +48.5%
Other Assets, Current 798K USD -59%
Assets, Current 172M USD +35.3%
Property, Plant and Equipment, Net 467K USD -0.43%
Operating Lease, Right-of-Use Asset 2.54M USD +31.8%
Goodwill 16.8M USD 0%
Other Assets, Noncurrent 7.38M USD -37.3%
Assets 199M USD +26%
Accounts Payable, Current 12.6M USD +58.9%
Accrued Liabilities, Current 44.2M USD +30.2%
Liabilities, Current 62.5M USD +46.1%
Operating Lease, Liability, Noncurrent 1.81M USD +48.8%
Other Liabilities, Noncurrent 2.1M USD -59.3%
Liabilities 101M USD +21.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23.6M USD +0.95%
Retained Earnings (Accumulated Deficit) -790M USD -0.04%
Stockholders' Equity Attributable to Parent 98.2M USD +31.6%
Liabilities and Equity 199M USD +26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.23M USD +72.3%
Net Cash Provided by (Used in) Financing Activities 690K USD -94.8%
Net Cash Provided by (Used in) Investing Activities 12.3M USD -42.4%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 97.2M shares +0.93%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5M USD +8.04%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 79.8M USD +179%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.89M USD +159%
Deferred Tax Assets, Valuation Allowance 102M USD +5.33%
Deferred Tax Assets, Gross 102M USD +5.33%
Operating Lease, Liability 1.7M USD -35.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52K USD +99.9%
Lessee, Operating Lease, Liability, to be Paid 1.95M USD -35.8%
Operating Lease, Liability, Current 740K USD +2.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 477K USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 683K USD -37.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +12.8%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 249K USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 477K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 68.6M USD -3.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 2.72M USD -10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 316K USD -33.8%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%